XA
Beyond Air, Inc.
XAIR · NASDAQ
$2.82 -3.75% (-$0.11)
1M -19.06%
Market Cap $2.06M
P/E Ratio -
Div. Yield -
ROE 462.50%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 1.03x
P/S 0.27x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 45.53%
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak Net margin 435.71%
Op. margin 364.76%
FCF margin 254.96%
Quality
3 /100
Poor ROE 462.50%
ROA 101.83%
Asset turnover 0.23x
Debt
54 /100
Moderate Current ratio 3.31x
Int. coverage -35.24x
Debt/Equity 0.72x
Stability
25 /100
Unstable EPS volatility 37.24%
Profitable years 0
Beta 0.15x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about XAIR
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert Goodman
Employees
54
Headquarters
Garden City
Upcoming events
10 NOV
Earnings
Upcoming earnings report